Michael Loh – författare

"I've worked with simulation in business for over 20 years, and Allman really nails it with this book. I admit that I own his previous book on structured finance cash flows, but I was surprised by what I found in here. He addresses the fundamental questions of how decision makers react to simulations and his read was very much in accordance with what I've experienced myself. When it came to the nuts and bolts of describing the different types of simulation analysis the book becomes incredibly detailed. There is working code and models for a fantastic array of the most common simulation problems. If you're so inclined, the book very carefully steps through the tricky math needed to really understand the theory behind stochastic modeling in finance. If you're preparing models that include any kind of randomization or stochastic modeling component, this book is a must-read, a tremendous value and time-saver." — David Brode of The Brode Group A practical guide to understanding and implementing financial simulation modelingAs simulation techniques become more popular among the financial community and a variety of sub-industries, a thorough understanding of theory and implementation is critical for practitioners involved in portfolio management, risk management, pricing, and capital budgeting. Financial Simulation Modeling in Excel contains the information you need to make the most informed decisions possible in your professional endeavors.Financial Simulation Modeling in Excel contains a practical, hands-on approach to learning complex financial simulation methodologies using Excel and VBA as a medium. Crafted in an easy to understand format, this book is suitable for anyone with a basic understanding of finance and Excel. Filled with in-depth insights and expert advice, each chapter takes you through the theory behind a simulation topic and the implementation of that same topic in Excel/VBA in a step-by-step manner. Organized in an easy-to-follow fashion, this guide effectively walks you through the process of creating and implementing risk models in ExcelA companion website contains all the Excel models risk experts and quantitative analysts need to practice and confirm their results as they progressKeith Allman is the author of other successful modeling books, including Corporate Valuation Modeling and Modeling Structured Finance Cash Flows with Microsoft ExcelCreated for those with some background in finance and experience in Excel, this reliable resource shows you how to effectively perform sound financial simulation modeling, even if you've yet to do extensive modeling up to this point in your professional or academic career.

"I''ve worked with simulation in business for over 20 years, and Allman really nails it with this book. I admit that I own his previous book on structured finance cash flows, but I was surprised by what I found in here. He addresses the fundamental questions of how decision makers react to simulations and his read was very much in accordance with what I''ve experienced myself. When it came to the nuts and bolts of describing the different types of simulation analysis the book becomes incredibly detailed. There is working code and models for a fantastic array of the most common simulation problems. If you''re so inclined, the book very carefully steps through the tricky math needed to really understand the theory behind stochastic modeling in finance. If you''re preparing models that include any kind of randomization or stochastic modeling component, this book is a must-read, a tremendous value and time-saver." — David Brode of The Brode Group

A practical guide to understanding and implementing financial simulation modeling

As simulation techniques become more popular among the financial community and a variety of sub-industries, a thorough understanding of theory and implementation is critical for practitioners involved in portfolio management, risk management, pricing, and capital budgeting. Financial Simulation Modeling in Excel contains the information you need to make the most informed decisions possible in your professional endeavors.

Financial Simulation Modeling in Excel contains a practical, hands-on approach to learning complex financial simulation methodologies using Excel and VBA as a medium. Crafted in an easy to understand format, this book is suitable for anyone with a basic understanding of finance and Excel. Filled with in-depth insights and expert advice, each chapter takes you through the theory behind a simulation topic and the implementation of that same topic in Excel/VBA in a step-by-step manner.

Organized in an easy-to-follow fashion, this guide effectively walks you through the process of creating and implementing risk models in Excel A companion website contains all the Excel models risk experts and quantitative analysts need to practice and confirm their results as they progress Keith Allman is the author of other successful modeling books, including Corporate Valuation Modeling and Modeling Structured Finance Cash Flows with Microsoft Excel

Created for those with some background in finance and experience in Excel, this reliable resource shows you how to effectively perform sound financial simulation modeling, even if you''ve yet to do extensive modeling up to this point in your professional or academic career.

"I''ve worked with simulation in business for over 20 years, and Allman really nails it with this book. I admit that I own his previous book on structured finance cash flows, but I was surprised by what I found in here. He addresses the fundamental questions of how decision makers react to simulations and his read was very much in accordance with what I''ve experienced myself. When it came to the nuts and bolts of describing the different types of simulation analysis the book becomes incredibly detailed. There is working code and models for a fantastic array of the most common simulation problems. If you''re so inclined, the book very carefully steps through the tricky math needed to really understand the theory behind stochastic modeling in finance. If you''re preparing models that include any kind of randomization or stochastic modeling component, this book is a must-read, a tremendous value and time-saver." — David Brode of The Brode Group

A practical guide to understanding and implementing financial simulation modeling

As simulation techniques become more popular among the financial community and a variety of sub-industries, a thorough understanding of theory and implementation is critical for practitioners involved in portfolio management, risk management, pricing, and capital budgeting. Financial Simulation Modeling in Excel contains the information you need to make the most informed decisions possible in your professional endeavors.

Financial Simulation Modeling in Excel contains a practical, hands-on approach to learning complex financial simulation methodologies using Excel and VBA as a medium. Crafted in an easy to understand format, this book is suitable for anyone with a basic understanding of finance and Excel. Filled with in-depth insights and expert advice, each chapter takes you through the theory behind a simulation topic and the implementation of that same topic in Excel/VBA in a step-by-step manner.

Organized in an easy-to-follow fashion, this guide effectively walks you through the process of creating and implementing risk models in Excel A companion website contains all the Excel models risk experts and quantitative analysts need to practice and confirm their results as they progress Keith Allman is the author of other successful modeling books, including Corporate Valuation Modeling and Modeling Structured Finance Cash Flows with Microsoft Excel

Created for those with some background in finance and experience in Excel, this reliable resource shows you how to effectively perform sound financial simulation modeling, even if you''ve yet to do extensive modeling up to this point in your professional or academic career.

This book is published in association with the Office of Health Economics. This book is a vital, non-technical guide illuminating recent developments within the five major European pharmaceutical markets. It clearly explains pharmaceutical regulatory policies on pricing and reimbursement, and their effects. Each chapter gives an overview of the current market, including aims, effectiveness, local markets, frameworks and politics, and then offers predictions for the next decade. Pharmaceutical executives with interests in marketing, market access and pricing will find this guide invaluable, as will health economists, government advisors and public affairs consultants. Public policy makers in areas such as the Department of Health and The Treasury and senior health service managers in hospitals will find it enlightening. It is also highly relevant to policy shapers in academia and the media, and undergraduate and postgraduate students of health economics, health policy, pharmaceutical economics and healthcare management. "This book aims not only to understand and discuss the mix of regulatory measures introduced by national policy makers in order to achieve their goals, but also to ascertain how these policies have actually shaped and influenced the characteristics and functioning of national pharmaceutical markets. In particular, each author has provided an analysis of existing pricing and reimbursement arrangements operating in their own country and an outline of policy scenarios that might emerge in the next decade." - Martina Garau and Jorge Mestre-Ferrandiz, in the Introduction.

Clinicians increasingly need a firm grasp of the fundamental principles of business management, finance and related subjects. Even so, business disciplines are still rarely taught during medical training, while busy practices and complicated accounting tasks mean that gaining business acumen ''on the job'' is impractical for many. As a result, increasing numbers of clinicians learn the skills they need by taking an MBA (Masters in Business Administration). While an MBA may be the answer for some, the formidable costs and time commitment it demands leave many busy practitioners seeking more accessible options. This book provides a readable, tightly organised alternative - a primer on MBA principles and their practical application. Twelve compact, carefully structured modules cover the entire gamut of a business education, from basic finance and accounting principles, to strategic management methods and leadership theories. Unlike some similar texts, this book is designed to be light in tone, easy to read and digest, and thoroughly practical. Busy clinicians, academic surgeons, administrative physicians and other healthcare professionals will find this an invaluable resource in understanding the core principles of business management. Allied medical professionals, and nurses will also find it useful, as will interview candidates who increasingly face management questions as part of selection processes. ''An invaluable resource in understanding the core principles of business management, and in learning how to apply them. For busy clinicians, the value proposition is enormous in terms of the knowledge gained, versus the amount of reading required to capture what the authors have so capably managed to distill between the covers. The authors have done a remarkable task in capturing the latest concepts and thinking in the business management arena [and] the essence of an entire MBA education, and customise it for healthcare professionals. A delight.'' From the Foreword by B Sonny Bal

This book is published in association with the Office of Health Economics. This book is a vital, non-technical guide illuminating recent developments within the five major European pharmaceutical markets. It clearly explains pharmaceutical regulatory policies on pricing and reimbursement, and their effects. Each chapter gives an overview of the current market, including aims, effectiveness, local markets, frameworks and politics, and then offers predictions for the next decade. Pharmaceutical executives with interests in marketing, market access and pricing will find this guide invaluable, as will health economists, government advisors and public affairs consultants. Public policy makers in areas such as the Department of Health and The Treasury and senior health service managers in hospitals will find it enlightening. It is also highly relevant to policy shapers in academia and the media, and undergraduate and postgraduate students of health economics, health policy, pharmaceutical economics and healthcare management. "This book aims not only to understand and discuss the mix of regulatory measures introduced by national policy makers in order to achieve their goals, but also to ascertain how these policies have actually shaped and influenced the characteristics and functioning of national pharmaceutical markets. In particular, each author has provided an analysis of existing pricing and reimbursement arrangements operating in their own country and an outline of policy scenarios that might emerge in the next decade." - Martina Garau and Jorge Mestre-Ferrandiz, in the Introduction.

Clinicians increasingly need a firm grasp of the fundamental principles of business management, finance and related subjects. Even so, business disciplines are still rarely taught during medical training, while busy practices and complicated accounting tasks mean that gaining business acumen ''on the job'' is impractical for many. As a result, increasing numbers of clinicians learn the skills they need by taking an MBA (Masters in Business Administration). While an MBA may be the answer for some, the formidable costs and time commitment it demands leave many busy practitioners seeking more accessible options. This book provides a readable, tightly organised alternative - a primer on MBA principles and their practical application. Twelve compact, carefully structured modules cover the entire gamut of a business education, from basic finance and accounting principles, to strategic management methods and leadership theories. Unlike some similar texts, this book is designed to be light in tone, easy to read and digest, and thoroughly practical. Busy clinicians, academic surgeons, administrative physicians and other healthcare professionals will find this an invaluable resource in understanding the core principles of business management. Allied medical professionals, and nurses will also find it useful, as will interview candidates who increasingly face management questions as part of selection processes. ''An invaluable resource in understanding the core principles of business management, and in learning how to apply them. For busy clinicians, the value proposition is enormous in terms of the knowledge gained, versus the amount of reading required to capture what the authors have so capably managed to distill between the covers. The authors have done a remarkable task in capturing the latest concepts and thinking in the business management arena [and] the essence of an entire MBA education, and customise it for healthcare professionals. A delight.'' From the Foreword by B Sonny Bal

This book is published in association with the Office of Health Economics. This book is a vital, non-technical guide illuminating recent developments within the five major European pharmaceutical markets. It clearly explains pharmaceutical regulatory policies on pricing and reimbursement, and their effects. Each chapter gives an overview of the current market, including aims, effectiveness, local markets, frameworks and politics, and then offers predictions for the next decade. Pharmaceutical executives with interests in marketing, market access and pricing will find this guide invaluable, as will health economists, government advisors and public affairs consultants. Public policy makers in areas such as the Department of Health and The Treasury and senior health service managers in hospitals will find it enlightening. It is also highly relevant to policy shapers in academia and the media, and undergraduate and postgraduate students of health economics, health policy, pharmaceutical economics and healthcare management. "This book aims not only to understand and discuss the mix of regulatory measures introduced by national policy makers in order to achieve their goals, but also to ascertain how these policies have actually shaped and influenced the characteristics and functioning of national pharmaceutical markets. In particular, each author has provided an analysis of existing pricing and reimbursement arrangements operating in their own country and an outline of policy scenarios that might emerge in the next decade." - Martina Garau and Jorge Mestre-Ferrandiz, in the Introduction.